Meredith Brown-Tuttle has over 34 years’ experience in the drug and device industry. Currently, she is Executive Director of Regulatory for Crinetics Pharmaceuticals, Inc. Previously, she was Chief Regulatory Strategist for Regulatorium, working with small and medium drug, biologic, and combination companies to successfully navigate global regulatory submissions, writing, intelligence, and strategy requirements as well as design AI regulatory tools and solutions. She has held senior regulatory positions at pharmaceutical, biologic, and advanced therapy companies writing global INDs, NDAs, and key meeting packages; negotiating NDA/BLA filings; and providing key drug development strategic insights. Meredith studied biological psychology as an undergraduate at San José State University. Her goal in life is to evolve and streamline global regulatory science through the development of AI tools. She has authored over 70 articles and 2 books (IND Submissions: A Primer and Regulatory Intelligence 101) and has trained thousands of people on how to write INDs and conduct strategy.

Peter de Florio is a results-driven Fintech executive with over two decades of experience building and scaling innovative, customer-centric products at the intersection of finance and technology. Most recently, as Chief Product Officer at AInvest, he architected one of the world's fastest-growing AI-native investing platforms, leading a global team to develop a sophisticated multi-model, multi-agent generative AI system that scaled to over one million users. His leadership has been instrumental in driving exponential growth; he was a key executive in scaling EasyKnock from a $200 million valuation to unicorn status. 

​

Prior to his work in the startup ecosystem, Peter held significant leadership roles at Prudential and E*TRADE where he created industry changing platforms and drove large-scale digital transformations as well as established enterprise-wide technology and design standards in highly regulated environments. His expertise lies in translating complex technologies—from AI platforms to financial APIs—into market-leading products that deliver significant commercial and strategic value. 

Luka Erceg is a senior executive and entrepreneur with a leadership background in high profile roles within the energy, specialty chemicals, technology, and corporate finance fields. In addition to leading organizations as the CEO, he has also served as a trusted advisor and confidante to many board and executive team members. 

One of his key strengths is to eliminate the complexity that restrains company and investment growth. He achieves performance excellence and outstanding results where others have relented. Utilizing strategic vision and an entrepreneurial spirit, he can raise significant capital to finance ventures and support organizational growth both organically and through mergers and acquisitions. 

His passion is to preserve and create outsized returns for the stakeholders he serves by developing and executing new strategies, implementing leading edge technology, and course correcting where needed. 

Luka holds the following degrees and designations: a Bachelor of Commerce from the University of Guelph, a J.D. from South Texas College of Law, an LL.M. from the University of Houston Law Center, an M.B.A. from Rice University; he is an Attorney and Counselor-at-Law licensed in the State of Texas; and he holds the C.I.R.A. designation from the Association of Insolvency & Restructuring Advisors (A.I.R.A.), the C.T.P. designation from the Turnaround Management Association (T.M.A.), and the FINRA Series 65.